Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

856 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Background to discuss guidelines for control of plasma HDL-cholesterol in Japan.
Yokoyama S, Yamashita S, Ishibashi S, Sone H, Oikawa S, Shirai K, Ohta T, Bujo H, Kobayashi J, Arai H, Harada-Shiba M, Eto M, Hayashi T, Gotoda T, Suzuki H, Yamada N. Yokoyama S, et al. Among authors: oikawa s. J Atheroscler Thromb. 2012;19(3):207-12. doi: 10.5551/jat.11452. Epub 2012 Jan 12. J Atheroscler Thromb. 2012. PMID: 22240911 Free article.
Management of type IIb dyslipidemia.
Arai H, Ishibashi S, Bujo H, Hayashi T, Yokoyama S, Oikawa S, Kobayashi J, Shirai K, Ota T, Yamashita S, Gotoda T, Harada-Shiba M, Sone H, Eto M, Suzuki H, Yamada N; Research Committee for Primary Hyperlipidemia, Research on Measures against Intractable Diseases by the Ministry of Health, Labour and Welfare in Japan. Arai H, et al. Among authors: oikawa s. J Atheroscler Thromb. 2012;19(2):105-14. doi: 10.5551/jat.10447. Epub 2011 Dec 3. J Atheroscler Thromb. 2012. PMID: 22139432 Free article.
The effects of partial use of formula diet on weight reduction and metabolic variables in obese type 2 diabetic patients--multicenter trial.
Shirai K, Saiki A, Oikawa S, Teramoto T, Yamada N, Ishibashi S, Tada N, Miyazaki S, Inoue I, Murano S, Sakane N, Satoh-Asahara N, Bujo H, Miyashita Y, Saito Y. Shirai K, et al. Among authors: oikawa s. Obes Res Clin Pract. 2013 Jan-Feb;7(1):e43-54. doi: 10.1016/j.orcp.2012.03.002. Obes Res Clin Pract. 2013. PMID: 24331681 Clinical Trial.
Predictive Value of the Cardio-Ankle Vascular Index for Cardiovascular Events in Patients at Cardiovascular Risk.
Miyoshi T, Ito H, Shirai K, Horinaka S, Higaki J, Yamamura S, Saiki A, Takahashi M, Masaki M, Okura T, Kotani K, Kubozono T, Yoshioka R, Kihara H, Hasegawa K, Satoh-Asahara N, Orimo H; CAVI‐J (Prospective Multicenter Study to Evaluate Usefulness of Cardio‐Ankle Vascular Index in Japan) investigators *. Miyoshi T, et al. J Am Heart Assoc. 2021 Aug 17;10(16):e020103. doi: 10.1161/JAHA.120.020103. Epub 2021 Aug 7. J Am Heart Assoc. 2021. PMID: 34369198 Free PMC article.
Diagnosis and management of type I and type V hyperlipoproteinemia.
Gotoda T, Shirai K, Ohta T, Kobayashi J, Yokoyama S, Oikawa S, Bujo H, Ishibashi S, Arai H, Yamashita S, Harada-Shiba M, Eto M, Hayashi T, Sone H, Suzuki H, Yamada N; Research Committee for Primary Hyperlipidemia, Research on Measures against Intractable Diseases by the Ministry of Health, Labour and Welfare in Japan. Gotoda T, et al. Among authors: oikawa s. J Atheroscler Thromb. 2012;19(1):1-12. doi: 10.5551/jat.10702. Epub 2011 Dec 1. J Atheroscler Thromb. 2012. PMID: 22129523 Free article.
Relation of Serum Lipoprotein(a) Levels to Lipoprotein and Apolipoprotein Profiles and Atherosclerotic Diseases in Japanese Patients with Heterozygous Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study.
Naito R, Daida H, Masuda D, Harada-Shiba M, Arai H, Bujo H, Ishibashi S, Koga N, Oikawa S, Yamashita S. Naito R, et al. Among authors: oikawa s. J Atheroscler Thromb. 2022 Aug 1;29(8):1188-1200. doi: 10.5551/jat.63019. Epub 2021 Aug 30. J Atheroscler Thromb. 2022. PMID: 34456199 Free PMC article.
Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).
Saito Y, Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K; JELIS Investigators, Japan. Saito Y, et al. Among authors: oikawa s. Atherosclerosis. 2008 Sep;200(1):135-40. doi: 10.1016/j.atherosclerosis.2008.06.003. Epub 2008 Jun 19. Atherosclerosis. 2008. PMID: 18667204 Clinical Trial.
Components of metabolic syndrome and their combinations as predictors of cardiovascular disease in Japanese patients with type 2 diabetes. Implications for improved definition. Analysis from Japan Diabetes Complications Study (JDCS).
Sone H, Tanaka S, Iimuro S, Oida K, Yamasaki Y, Oikawa S, Ishibashi S, Katayama S, Ito H, Ohashi Y, Akanuma Y, Yamada N. Sone H, et al. Among authors: oikawa s. J Atheroscler Thromb. 2009 Aug;16(4):380-7. doi: 10.5551/jat.no117. Epub 2009 Aug 11. J Atheroscler Thromb. 2009. PMID: 19672033 Free article.
856 results